Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.49
-0.09 (-1.19%)
Apr 29, 2025, 1:13 PM EDT - Market open
Journey Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 20.31 | 27.44 | 32 | 49.08 | 8.25 | Upgrade
|
| Cash & Short-Term Investments | 20.31 | 27.44 | 32 | 49.08 | 8.25 | Upgrade
|
| Cash Growth | -26.00% | -14.26% | -34.80% | 495.21% | 71.76% | Upgrade
|
| Receivables | 10.23 | 15.22 | 28.21 | 23.11 | 23.93 | Upgrade
|
| Inventory | 14.43 | 10.21 | 14.16 | 9.86 | 1.4 | Upgrade
|
| Prepaid Expenses | 3.21 | 3.59 | 3.31 | 2.44 | 1.66 | Upgrade
|
| Total Current Assets | 48.18 | 56.46 | 77.68 | 84.49 | 35.24 | Upgrade
|
| Property, Plant & Equipment | 0.2 | 0.1 | 0.19 | 0.09 | 0.18 | Upgrade
|
| Other Intangible Assets | 31.86 | 20.29 | 27.2 | 12.55 | 15.03 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 1.45 | Upgrade
|
| Other Long-Term Assets | - | 0.01 | 0.1 | 0.15 | 0.01 | Upgrade
|
| Total Assets | 80.24 | 76.85 | 105.16 | 97.28 | 51.91 | Upgrade
|
| Accounts Payable | 16.05 | 18.15 | 36.57 | 22.81 | 1.86 | Upgrade
|
| Accrued Expenses | 15.23 | 16.49 | 16.27 | 20.09 | 19.02 | Upgrade
|
| Short-Term Debt | - | - | 2.95 | 0.81 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.63 | 3 | 2.24 | 4.51 | 4.52 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.1 | 0.08 | 0.1 | 0.09 | Upgrade
|
| Current Income Taxes Payable | 0.06 | 0.05 | 0.04 | 0.01 | - | Upgrade
|
| Other Current Liabilities | 3.12 | 4.08 | 8.68 | 3.28 | 2.58 | Upgrade
|
| Total Current Liabilities | 35.18 | 41.87 | 66.83 | 51.61 | 28.06 | Upgrade
|
| Long-Term Debt | 24.88 | 14.62 | 21.24 | 3.63 | 13.36 | Upgrade
|
| Long-Term Leases | 0.12 | 0.01 | 0.11 | - | 0.1 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.1 | Upgrade
|
| Total Liabilities | 60.17 | 56.5 | 88.18 | 55.24 | 41.61 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 107.09 | 92.7 | 85.48 | 80.92 | 5.17 | Upgrade
|
| Retained Earnings | -87.03 | -72.36 | -68.5 | -38.87 | 5.12 | Upgrade
|
| Shareholders' Equity | 20.07 | 20.35 | 16.98 | 42.04 | 10.29 | Upgrade
|
| Total Liabilities & Equity | 80.24 | 76.85 | 105.16 | 97.28 | 51.91 | Upgrade
|
| Total Debt | 25.71 | 17.73 | 26.62 | 9.05 | 18.06 | Upgrade
|
| Net Cash (Debt) | -5.4 | 9.71 | 5.38 | 40.03 | -9.82 | Upgrade
|
| Net Cash Growth | - | 80.40% | -86.56% | - | - | Upgrade
|
| Net Cash Per Share | -0.26 | 0.53 | 0.31 | 3.93 | -0.91 | Upgrade
|
| Filing Date Shares Outstanding | 23.1 | 19.93 | 17.83 | 17.32 | 9.15 | Upgrade
|
| Total Common Shares Outstanding | 22.15 | 19.32 | 17.77 | 17.32 | 9.15 | Upgrade
|
| Working Capital | 13 | 14.59 | 10.85 | 32.88 | 7.18 | Upgrade
|
| Book Value Per Share | 0.91 | 1.05 | 0.96 | 2.43 | 1.12 | Upgrade
|
| Tangible Book Value | -11.79 | 0.06 | -10.22 | 29.49 | -4.74 | Upgrade
|
| Tangible Book Value Per Share | -0.53 | 0.00 | -0.57 | 1.70 | -0.52 | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.